Skip to main content
. 2021 Mar 23;21:304. doi: 10.1186/s12885-021-08049-3

Table 2.

Results of Cox proportional hazard model analysis of survival data

Univariate analysis Multivariate analysis (n = 112)
variables n estimates S.E. HR 95% CI p estimates S.E. HR 95% CI p
QLQ-C15-PAL
 Physical Functioning 125 −0.001 0.004 0.999 0.991–1.006 .738
 Emotional Functioning 129 0.001 0.003 1.001 0.994–1.008 .809
 Dyspnea 130 0.010 0.003 1.010 1.005–1.016 < .001** 0.012 0.003 1.012 1.005–1.019 < .001**
 Pain 129 −0.0004 0.003 1.000 0.994–1.005 .878
 Insomnia 130 0.001 0.003 1.001 0.996–1.006 .608
 Appetite Loss 130 0.005 0.003 1.005 1.000–1.010 .073
 Constipation 128 0.0003 0.003 1.000 0.995–1.006 .922
 Fatigue 129 0.011 0.003 1.011 1.004–1.017 .002** 0.009 0.004 1.009 1.001–1.016 .024*
 Nausea/Vomiting 130 0.002 0.003 1.002 0.995–1.008 .597
 QOL 124 −0.007 0.004 0.993 0.986–1.000 .055
Inflammatory Biomarkers
 CRP 126 0.049 0.014 1.050 1.022–1.079 < .001**
 Alb 126 −0.465 0.171 0.628 0.449–0.878 .007** −0.457 0.180 0.633 0.445–0.902 .011*
 NLR 122 0.017 0.003 1.017 1.012–1.023 < .001** 0.015 0.003 1.015 1.009–1.021 < .001**

*p < .05, **p < .01; estimates = regression coefficients, S.E.: Standard errors of estimates; all QLQ-C15-PAL scale scores were linearly transformed, and the resultant scores ranged from 0 to 100. Alb albumin, CI confidence interval, CRP C-reactive protein, HR hazard ratio, NLR neutrophil-lymphocyte ratio, QLQ-C15-PAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care, QOL quality of life